P2.01-60 Clinical Utility of Circulating Tumor Cell (CTC) Analysis Using Target Selector™ in Metastatic NSCLC Chemotherapy Patients

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1114
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.01-95 Assesment the Fitness for Chemotherapy of NSCLC Patients Using 6MWT

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients

Cancers
Cancer ResearchOncology
2020English

P2.01-100 Different Genetic Mutations Enriched in Circulating Tumor DNA Predict Different Metastatic Sites in Lung Adenocarcinoma Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-87 Profiling the Symptom Burden of Patients With Metastatic NSCLC Receiving Either Chemotherapy or Targeted Therapy: Real-World Data

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Clinical Utility of Circulating Tumor Cell Measurement in the Diagnosis of Indeterminate Lesions of the Pancreas

Future Oncology
MedicineCancer ResearchOncology
2010English

Using Circulating Tumor Cells to Inform on Prostate Cancer Biology and Clinical Utility

Critical Reviews in Clinical Laboratory Sciences
BiochemistryClinical BiochemistryGeneticsMolecular Biology
2015English

The Clinical Utility of Circulating Tumour Cells in Patients With Small Cell Lung Cancer

Translational Lung Cancer Research
Oncology
2017English

Clinical Significance of Peripheral Circulating Tumor Cell Counts in Colorectal Polyps and Non-Metastatic Colorectal Cancer

World Journal of Surgical Oncology
SurgeryOncology
2018English

Detection of Circulating Tumor Cells: Clinical Relevance of a Novel Metastatic Tumor Marker

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy